Evidence map›Paper›PMID 33934268›Full record

ArticleEJNMMI research2021

Head to head comparison of [

Andrew T Taylor, Malgorzata Lipowska, Raghuveer K Halkar

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Andrew T TaylorDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, 30322, USA. ataylor@emory.edu.ORCID http://orcid.org/0000-0003-3709-6846
Malgorzata LipowskaDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, 30322, USA.
Raghuveer K HalkarDepartment of Radiology and Imaging Sciences, Emory University, Atlanta, GA, 30322, USA.

Funding

Development of Tc-99m Renal Tubular TracersR37DK038842 · NIDDK · EMORY UNIVERSITY · PI TAYLOR, ANDREW THOMPSON · 2009 to 2017
$3.4M
Development and Assessment of Decision Supporting System for Renal studiesR01DK108070 · NIDDK · EMORY UNIVERSITY · PI MANATUNGA, AMITA K. · 2016 to 2020
$1.7M
NIDDK NIH HHS R01 DK108070NIDDK NIH HHS R37 DK038842NIDDK NIH HHS R37 DK38842
6 · The paper itself

Abstract

purpose

methods[

resultsThe clearance of NTA was greater than that of MAG3, 331 ± 146 versus 271 ± 105 mL/min/1.73 m

conclusionsUnlike MAG3, NTA is not eliminated via the hepatobiliary track. Moreover, NTA has a higher kidney to background ratio and more rapid clearance than MAG3. These advantages should allow more robust camera-based clearance measurements and may lead to better discrimination between obstructed and non-obstructed kidneys.

Indexed as

99mTc(CO)3(NTA)99mTc-MAG399mTc-mercaptoacetyltriglycine99mTc-tricarbonylnitrilotriacetic acidDiuretic renographyMAG3NTARenal radiopharmaceuticals

Identifiers

PMID33934268
PMCPMC8088423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.